https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Juxtamembrane mutant V560GKit is more sensitive to Imatinib (ST1571) compared with wild-type c-Kit whereas the kinase domain mutant D816VKit is resistant https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1418 Sat 24 Mar 2018 08:28:14 AEDT ]]> Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:5045 Sat 24 Mar 2018 07:45:38 AEDT ]]>